Get the latest perspectives on real world data and evidence.

STATinMED Research Fall Newsletter 2021

With access to more than 80% of the US healthcare system, we use patient-level data across all-provider types to support evidence generation needs.

Read More

Rare Diseases: Not So Rare Within Real-World Data

Rare diseases are not so rare in RWD. Accounting for variability in access to care based on payer and healthcare infrastructure, our claims data population in STATinMED RWD Insights can help to monitor the outcomes for those with rare diseases and identify gaps in available therapeutics and healthcare resources.

Read More

Social Determinants of Health: What We See in RWE

Through real-world evidence (RWE), prescriptions reveal the process and delivery of healthcare. A prescription for a diagnostic test or medication reflects medical practice patterns, healthcare systems, and payer reimbursement for services.

Read More

How to Maximize RWD Insights in Precision Medicine for Patients with Cancer

With STATinMED RWD Insights we have the power to examine more than 80% of the US healthcare system’s all-payer medical and pharmacy claims, with patient-level data across all-provider types to support a variety of evidence generation needs.

Read More

STATinMED Research News Quarterly – Summer 2021

STATinMED Research is pleased to share the latest updates in our summer newsletter, as we celebrate our new brand and company website.

Read More

Sourcing Outcomes Data

Data sourcing can be challenging. Identifying optimal data sources requires extensive insight into the data landscape relative to specific research needs. Successful data sourcing will require a balancing act between research priorities and data availability.

Read More

Sign up to receive communications